Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: Data from the ARTISTIC trial

Journal of Clinical Microbiology

Volumn 48, Issue 2, 2010, Pages 554-558

  Sargent, A ^a   Bailey, A ^a   Turner, A ^a   Almonte, M ^c   Gilham, C ^d   Baysson, H ^e   Peto, J ^e   Roberts, C ^b   Thomson, C ^a   Desai, M ^a   Mather, J ^a   Kitchener, H ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EMERGENCY HEALTH SERVICE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SCREENING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS DIAGNOSIS;

ADULT; CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 75649093342     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00896-09     Document Type: Article

References (16)

1. Bory, J. P., J. Cucherousset, M. Lorenzato, R. Gabriel, C. Quereux, P. Birembaut, and C. Clavel. 2002. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int. J. Cancer 102:519-525.
2. Bosch, F. X., A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah. 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265.
3. Castle, P. E., M. Schiffman, R. D. Burk, S. Wacholder, A. Hildesheim, R. Herrero, M. C. Bratti, M. E. Sherman, and A. Lorincz. 2002. Restricted cross-reactivity of Hybrid Capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol. Biomarkers Prev. 11:1394-1399.
4. Castle, P. E., P. E. Gravitt, D. Solomon, C. M. Wheeler, and M. Schiffman. 2008. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study. J. Clin. Microbiol. 46:109-117.
5. Clavel, C., M. Masure, J. P. Bory, I. Putand, C. Mangeonjean, M. Lorenzato, P. Nazeyrollas, R. Gabriel, C. Quereux, and P. Birembaut. 2001. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br. J. Cancer 84:1616-1623.
6. Ho, G. Y., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
7. Kitchener, H. C., M. Almonte, C. Thomson, P. Wheeler, A. Sargent, B. Stoykova, C. Gilham, H. Baysson, C. Roberts, R. Dowie, M. Desai, J. Mather, A. Bailey, A. Turner, S. Moss, and J. Peto. 18 June 2009. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol. doi:10.1016/S1470-2045(09)70156-1.
8. Kulasingam, S. L., J. P. Hughes, N. B. Kiviat, C. Mao, N. S. Weiss, J. M. Kuypers, and L. A. Koutsky. 2002. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 288:1749-1757.
9. Kulmala, S.-M., S. Syrjanen, I. Shabalova, N. Patrovichev, V. Kozachenko, J. Podistov, O. Ivanchenko, S. Zakharenko, R. Nerovjna, L. Kljukina, M. Branovskaja, V. Grunberga, A. Juschenko, P. Tosi, R. Santopietro, K. Syrjanen, and the NIS Cohort Study Group. 2004. Human papillomavirus testing with the Hybrid Capture 2 assay and PCR as screening tools. J. Clin. Microbiol. 42:2470-2475.
10. Peyton, C. L., M. Schiffman, A. T. Lorincz, W. C. Hunt, I. Mielzynska, C. Bratti, S. Eaton, A. Hildesheim, L. A. Morera, A. C. Rodriguez, R. Herrero, M. E. Sherman, and C. M. Wheeler. 1998. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J. Clin. Microbiol. 36:3248-3254.
11. Richardson, H., G. Kelsall, P. Tellier, H. Voyer, M. Abrahamowicz, A. Ferenczy, F. Coutlee, and E. L. Franco. 2003. The natural history of typespecific human papillomavirus infections in female university students. Cancer Epidemiol. Biomarkers Prev. 12:485-490.
12. Sargent, A., A. Bailey, M. Almonte, A. Turner, C. Thomson, J. Peto, M. Desai, J. Mather, S. Moss, C. Roberts, and H. C. Kitchener on behalf of the ARTISTIC Trial Steering Group. 2008. Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br. J. Cancer 98:1704-1709.
13. Schiffman, M., R. Herrero, A. Hildesheim, M. E. Sherman, M. Bratti, S. Wacholder, M. Alfaro, M. Hutchinson, J. Morales, M. D. Greenberg, and A. T. Lorincz. 2000. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 283:87-93.
14. Terry, G., L. Ho, P. Londesborough, J. Cuzick, I. Mielzynska-Lohnas, and A. Lorincz. 2001. Detection of high-risk HPV types by the Hybrid Capture 2 test. J. Med. Virol. 65:155-162.
15. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
16. zur Hausen, H. 2000. Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690-698.